TARIVID 200 MG SOLUTION FOR INTRAVENOUS INFUSION
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OFLOXACIN 2 MG/ML
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
J01MA01
Pharmaceutical form:
SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY
Therapeutic group:
OFLOXACIN
Therapeutic indications:
Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections,
Authorization date:
2010-11-01
